Startseite>>Lipids>> Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids>>5R(6S)-EET

5R(6S)-EET (Synonyms: 5R(6S)-EpETrE,5R(6S)-epoxy-all-cis-8,11,14-Eicosatrienoic Acid,5R(6S)-Epoxyeicosatrienoic Acid,5R(6S)-epoxy-8(Z),11(Z),14(Z)-ETrE,FA 20:4;O)

Katalog-Nr.GC91695

5R(6S)-EET is an oxylipin.

Products are for research use only. Not for human use. We do not sell to patients.

5R(6S)-EET Chemische Struktur

Cas No.: 98103-46-9

Größe Preis Lagerbestand Menge
25 µg
402,00 $
Auf Lager
50 µg
724,00 $
Auf Lager
100 µg
1.285,00 $
Auf Lager
500 µg
5.625,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

5R(6S)-EET is an oxylipin. It depolarizes transepithelial voltage in isolated rabbit renal cortical collecting duct when applied to the luminal side at a concentration of 1 µM to a lesser extent than 5S(6R)-EET .[1] In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS.[2]

References:
[1].Sakairi, Y., Jacobson, H.R., Noland, T.D., et al.5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesisAm. J. Physiol.268(5 Pt 2)F931-F939(1995).
[2].Rashid, M., Manivet, P., Nishio, H., et al.Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modelingLife Sci.73(2)193-207(2003).

Bewertungen

Review for 5R(6S)-EET

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5R(6S)-EET

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.